Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Lillicrap

Showing results (201-210 of 216) with videos related to

Pageof 22
Sort By:
Trials|March 11, 2021
Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trialMichelle Sholzberg, Grace H Tang, Elnara Negri, et al.
Research and Practice in Thrombosis and Haemostasis|July 27, 2018
Advances in Clinical and Basic Science of Coagulation: Illustrated abstracts of the 9th Chapel Hill Symposium on HemostasisWolfgang Bergmeier, Silvio Antoniak, Edward M Conway, et al.
Science Translational Medicine|February 21, 2024
Lipid nanoparticles and siRNA targeting plasminogen provide lasting inhibition of fibrinolysis in mouse and dog models of hemophilia AAmy W Strilchuk, Woosuk S Hur, Paul Batty, et al.
Hemasphere|March 26, 2025
Mild or moderate hemophilia is not always a mild or moderate bleeding disorder: Back to the clinical phenotypeFrancesco Rodeghiero, Lisanna Ghiotto, Luca Pontalto, et al.
Blood Transfusion = Trasfusione Del Sangue|November 29, 2016
Summary report of the First International Conference on inhibitors in haemophilia ASebastien Lacroix-Desmazes, David W Scott, Jenny Goudemand, et al.
Journal of Applied Toxicology : JAT|January 4, 2018
A call for action: Improve reporting of research studies to increase the scientific basis for regulatory decision-makingMarlene Ågerstrand, Sofie Christiansen, Annika Hanberg, et al.
Research Square|October 27, 2023
A Scan of Pleiotropic Immune Mediated Disease Genes Identifies Novel Determinants of Baseline FVIII Inhibitor Status in Hemophilia-ATom Howard, Marcio Almieda, Vincent Diego, et al.
Blood|February 11, 2016
Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United StatesVeronica H Flood, Pamela A Christopherson, Joan Cox Gill, et al.
Research and Practice in Thrombosis and Haemostasis|November 19, 2024
Prediction of the chance of successful immune tolerance induction in persons with severe hemophilia A and inhibitors: a clinical prediction modelIlja Oomen, Amal Abdi, Ricardo M Camelo, et al.
BMJ (Clinical Research Ed.)|October 15, 2021
Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trialMichelle Sholzberg, Grace H Tang, Hassan Rahhal, et al.
Pageof 22

Showing results (201-210 of 216) with videos related to

Sort By:
Pageof 22
Trials|March 11, 2021
Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trialMichelle Sholzberg, Grace H Tang, Elnara Negri, et al.
Research and Practice in Thrombosis and Haemostasis|July 27, 2018
Advances in Clinical and Basic Science of Coagulation: Illustrated abstracts of the 9th Chapel Hill Symposium on HemostasisWolfgang Bergmeier, Silvio Antoniak, Edward M Conway, et al.
Science Translational Medicine|February 21, 2024
Lipid nanoparticles and siRNA targeting plasminogen provide lasting inhibition of fibrinolysis in mouse and dog models of hemophilia AAmy W Strilchuk, Woosuk S Hur, Paul Batty, et al.
Hemasphere|March 26, 2025
Mild or moderate hemophilia is not always a mild or moderate bleeding disorder: Back to the clinical phenotypeFrancesco Rodeghiero, Lisanna Ghiotto, Luca Pontalto, et al.
Blood Transfusion = Trasfusione Del Sangue|November 29, 2016
Summary report of the First International Conference on inhibitors in haemophilia ASebastien Lacroix-Desmazes, David W Scott, Jenny Goudemand, et al.
Journal of Applied Toxicology : JAT|January 4, 2018
A call for action: Improve reporting of research studies to increase the scientific basis for regulatory decision-makingMarlene Ågerstrand, Sofie Christiansen, Annika Hanberg, et al.
Research Square|October 27, 2023
A Scan of Pleiotropic Immune Mediated Disease Genes Identifies Novel Determinants of Baseline FVIII Inhibitor Status in Hemophilia-ATom Howard, Marcio Almieda, Vincent Diego, et al.
Blood|February 11, 2016
Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United StatesVeronica H Flood, Pamela A Christopherson, Joan Cox Gill, et al.
Research and Practice in Thrombosis and Haemostasis|November 19, 2024
Prediction of the chance of successful immune tolerance induction in persons with severe hemophilia A and inhibitors: a clinical prediction modelIlja Oomen, Amal Abdi, Ricardo M Camelo, et al.
BMJ (Clinical Research Ed.)|October 15, 2021
Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trialMichelle Sholzberg, Grace H Tang, Hassan Rahhal, et al.
Pageof 22